CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 166 filers reported holding CASTLE BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,815 | +23.1% | 1,410 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $19,345 | -39.6% | 1,410 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $32,035 | -3.5% | 1,410 | 0.0% | 0.00% | +100.0% |
| Q4 2022 | $33,191 | -9.7% | 1,410 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $36,773 | +18.8% | 1,410 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $30,950 | -51.1% | 1,410 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $63,253 | -75.3% | 1,410 | -76.4% | 0.00% | -33.3% |
| Q4 2021 | $256,148 | -35.5% | 5,975 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $397,338 | -9.3% | 5,975 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $438,147 | +51.4% | 5,975 | +41.4% | 0.01% | +50.0% |
| Q1 2021 | $289,380 | +32.2% | 4,227 | +29.7% | 0.00% | +33.3% |
| Q4 2020 | $218,842 | +30.5% | 3,259 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $167,676 | +36.5% | 3,259 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $122,832 | +26.4% | 3,259 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $97,151 | – | 3,259 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXT CENTURY GROWTH INVESTORS LLC | 538,673 | $24,164,000 | 2.41% |
| Pembroke Management, LTD | 463,909 | $20,811,000 | 1.74% |
| Redwood Investments, LLC | 375,892 | $16,863,000 | 1.60% |
| Monarch Partners Asset Management LLC | 156,502 | $7,021,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 33,170 | $1,488,000 | 1.22% |
| Mesirow Financial Investment Management, Inc. | 7,985 | $358,000 | 1.21% |
| Grandeur Peak Global Advisors, LLC | 544,723 | $24,436,000 | 1.16% |
| Granahan Investment Management | 793,715 | $35,606,000 | 0.88% |
| WASATCH ADVISORS LP | 3,443,847 | $154,491,000 | 0.76% |
| Intrinsic Edge Capital Management LLC | 212,400 | $9,528,000 | 0.73% |